Literature DB >> 18612689

Long-term outlook after successful fibrin glue ablation of cryptoglandular transsphincteric fistula-in-ano.

Timothy Adams1, Jonathan Yang, Laurie Ann Kondylis, Philip D Kondylis.   

Abstract

PURPOSE: Initial success rates for fibrin glue ablation of cryptoglandular transsphincteric fistulas have been disappointing. We examined long-term outcomes after initially successful fibrin glue ablation of cryptoglandular transsphincteric fistulas.
METHODS: Retrospective review identified 36 adult patients with cryptoglandular transsphincteric fistula Tisseel VH(R) fibrin glue ablation that was performed from May 2000 to March 2005. Fibrin glue ablations were performed under supervision of fellowship-trained colorectal surgeons. Follow-up interval was based on time until recurrence of fistula or time of last fistula-free evaluation.
RESULTS: Twenty-four men and 12 women patients had a mean age of 50 (range, 27-85) years. Twenty patients responded to initial fibrin glue ablation treatment. Two additional patients healed with secondary fibrin glue ablation. Sixty-six percent (22/33 patients) of cryptoglandular transsphincteric fistulas were closed at three months. Eleven patients failed fibrin glue ablation at a mean of 33 (range, 6-41) days. Seventeen of 22 short-term success patients (3 months) were available for long-term follow-up. Ninety-four percent (16/17 patients) remained healed at final long-term follow-up. The remaining patient recurred just before the six-month follow-up.
CONCLUSIONS: Despite the suboptimal early success rate of fibrin glue ablation for cryptoglandular transsphincteric fistulas, when a fistula does close for at least six months this appears to be a durable closure. A single patient recurred after appearing healed at the three-month check.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612689     DOI: 10.1007/s10350-008-9405-2

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  7 in total

1.  The role of loose seton in the management of anal fistula: a multicenter study of 200 patients.

Authors:  M E Kelly; H M Heneghan; F D McDermott; G J Nason; C Freeman; S T Martin; D C Winter
Journal:  Tech Coloproctol       Date:  2014-07-03       Impact factor: 3.781

2.  Platelet-rich fibrin sealant as a treatment for complex perianal fistulas: a multicentre study.

Authors:  F J Pérez Lara; A Moreno Serrano; J Ulecia Moreno; J Hernández Carmona; M Ferrer Marquez; L Romero Pérez; A del Rey Moreno; H Oliva Muñoz
Journal:  J Gastrointest Surg       Date:  2014-11-25       Impact factor: 3.452

Review 3.  The treatment of anal fistulas with biologically derived products: is innovation better than conventional surgical treatment? An update.

Authors:  Roberto Cirocchi; Stefano Trastulli; Umberto Morelli; Jacopo Desiderio; Carlo Boselli; Amilcare Parisi; Giuseppe Noya
Journal:  Tech Coloproctol       Date:  2012-12-04       Impact factor: 3.781

Review 4.  Biomaterials in the treatment of anal fistula: hope or hype?

Authors:  Daniele Scoglio; Avery S Walker; Alessandro Fichera
Journal:  Clin Colon Rectal Surg       Date:  2014-12

Review 5.  Idiopathic fistula-in-ano.

Authors:  Sherief Shawki; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2011-07-28       Impact factor: 5.742

6.  The role of fibrin glue in the treatment of high and low fistulas in ano.

Authors:  Atul Mishra; Sheerin Shah; Amandeep Singh Nar; Ashvind Bawa
Journal:  J Clin Diagn Res       Date:  2013-05-01

7.  Costs Analysis of Fibrin Sealant for Prevention of Anastomotic Leakage in Lower Colorectal Surgery.

Authors:  Saswat Panda; Mark P Connolly; Manuel G Ramirez; Juan Beltrán de Heredia
Journal:  Risk Manag Healthc Policy       Date:  2020-01-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.